BSE filing, NSE: INDOKEM. Summary written from the filing by ALFA Finder's alert engine.
Indokem Ltd: key numbers
- Share price
- ₹631.00
- Market cap
- ₹1,760 Cr
- Revenue (annual)
- ₹169.4 Cr
- Net profit (annual)
- ₹1.87 Cr
- P/E (TTM)
- 785.6×Sector 34.5×
- Promoter holding
- 68.58%-0.09% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indokem Ltd
All →Indokem Board Meeting Date
Indokem Limited scheduled a board meeting for November 2, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window has been closed since October 1, 2026.
Indokem Other Announcement
Indokem Limited filed the confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Indokem Promoter Selling: ₹0.14 Cr
Promoter Group entities Priyanilgiri Holdings Pvt Ltd and Vindhyapriya Holdings Pvt Ltd sold shares worth ₹0.14 Crore via market sales.
- Value
- ₹0.14 Cr
Indokem Promoter Selling: ₹0.01 Cr
Vindhyapriya Holdings Private Limited, part of the promoter group, sold 114 equity shares of Indokem Ltd in a market sale for Rs. 0.01 Crore.
- Value
- ₹0.01 Cr
Indokem Management Change
Indokem Limited announced the re-appointment of directors Mrs. Asha M. Khatau, Mr. Arupkumar Basu, and Mr. Manish M. Khatau, approved at the 60th AGM.
Indokem Annual General Meeting
Indokem Limited held its 60th Annual General Meeting on September 24, 2026. Shareholders transacted ordinary and special business items, including re-appointments and related party transaction approvals.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.